Silence Therapeutics plc (SLN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 421.29K | 34K | 159K | 224K | 142K | 24.33M | 1.14M | 598K | 15.7M | 2.1M | 2.8M | 9.1M |
| Revenue Growth % | 196.68% | -99.86% | -86.08% | -62.54% | -99.1% | 1059.02% | -59.19% | -93.43% | 38.03% | -55.95% | -17% | 149.9% |
| Cost of Goods Sold | 116.8K | 12K | 64K | 85K | 54K | 1.61M | 2.77M | 2.64M | 2.8M | 1.35M | 1.61M | 2.83M |
| COGS % of Revenue | 27.73% | 35.29% | 40.25% | 37.95% | 38.03% | 6.6% | 242.91% | 441.14% | 17.84% | 64.13% | 57.43% | 31.1% |
| Gross Profit | 304.49K | 22K | 95K | 139K | 88K | 22.72M | -1.63M | -2.04M | 12.9M | 753K | 1.19M | 6.27M |
| Gross Margin % | 72.27% | 64.71% | 59.75% | 62.05% | 61.97% | 93.4% | -142.91% | -341.14% | 82.16% | 35.87% | 42.57% | 68.9% |
| Gross Profit Growth % | 246.01% | -99.9% | 105.82% | 106.81% | -99.32% | 2917.47% | -237.03% | -132.52% | 88.58% | -16.89% | 21.9% | 385.9% |
| Operating Expenses | 15.33M | 12.48M | 26.34M | 24.1M | 28.5M | 25.8M | 20.91M | 16.28M | 18.48M | 14.05M | 13.89M | 17.73M |
| OpEx % of Revenue | 3637.68% | 36714.71% | 16565.41% | 10759.82% | 20068.31% | 106.05% | 1830.56% | 2722.91% | 117.71% | 669.46% | 496.43% | 194.75% |
| Selling, General & Admin | 7.03M | 3.73M | 5.79M | 5.13M | 7.68M | 5.4M | 5.6M | 5.29M | 6.63M | 4.12M | 4.96M | 5.12M |
| SG&A % of Revenue | 1667.73% | 10982.35% | 3644.65% | 2290.63% | 5411.27% | 22.18% | 490.37% | 884.28% | 42.26% | 196.05% | 177.13% | 56.18% |
| Research & Development | 8.34M | 8.75M | 20.54M | 17.65M | 20.81M | 20.4M | 15.3M | 10.99M | 11.85M | 9.94M | 8.93M | 12.62M |
| R&D % of Revenue | 1980.81% | 25732.35% | 12920.75% | 7878.13% | 14657.04% | 83.87% | 1340.19% | 1838.63% | 75.45% | 473.42% | 319.3% | 138.57% |
| Other Operating Expenses | -45.72K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.02M | -12.46M | -26.24M | -23.96M | -28.41M | -3.08M | -22.54M | -18.32M | -5.58M | -13.3M | -12.7M | -11.46M |
| Operating Margin % | -3565.41% | -36650% | -16505.66% | -10697.77% | -20006.34% | -12.65% | -1973.47% | -3064.05% | -35.55% | -633.59% | -453.86% | -125.85% |
| Operating Income Growth % | 47.13% | -304.79% | -16.45% | -30.78% | -409.03% | 76.85% | -77.47% | -59.93% | 54.06% | -21.33% | 6.77% | 18.68% |
| EBITDA | -14.91M | -12.35M | -26.09M | -23.82M | -28.27M | -2.96M | -22.42M | -18.2M | -5.43M | -13.18M | -12.57M | -11.34M |
| EBITDA Margin % | -3540.29% | -36317.65% | -16407.55% | -10631.7% | -19909.15% | -12.16% | -1963.4% | -3044.15% | -34.58% | -627.82% | -449.39% | -124.55% |
| EBITDA Growth % | 47.24% | -317.29% | -16.35% | -30.82% | -420.74% | 77.55% | -78.32% | -60.54% | 54.81% | -21.79% | 6.91% | 18.86% |
| D&A (Non-Cash Add-back) | 105.82K | 113K | 156K | 148K | 138K | 119.28K | 115K | 119K | 152K | 121K | 125K | 118K |
| EBIT | -15.02M | -12.46M | -20.96M | -22.64M | -28.41M | 7.07M | -21.56M | -17.26M | -3.09M | -15.03M | -10.65M | -11.12M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 12.43M | -7.62M | 882K | 791K | -928K | 2.04M | -553K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 886.95K | 981K | 1.06M | 804K | 0 | 2.05M | 340K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | -11.54M | 8.6M | 183K | 13K | 928K | 8K | 893K |
| Other Income/Expense | 88.85K | 691K | 5.29M | -3.38M | -121K | 26.81M | -7.62M | 882K | 3.51M | -1.67M | 2.04M | -553K |
| Pretax Income | -14.93M | -11.77M | -20.96M | -27.34M | -28.53M | 23.74M | -30.16M | -17.44M | -2.07M | -14.97M | -10.66M | -12.01M |
| Pretax Margin % | -3544.32% | -34617.65% | -13180.5% | -12207.14% | -20091.55% | 97.57% | -2640.81% | -2916.56% | -13.17% | -713.01% | -381.02% | -131.92% |
| Income Tax | 0 | 0 | 1K | 10K | 0 | 9.56M | -3.15M | -1.88M | 244K | -554K | -2.41M | -1.61M |
| Effective Tax Rate % | 0% | 0% | -0% | -0.04% | 0% | 40.28% | 10.43% | 10.77% | -11.8% | 3.7% | 22.62% | 13.4% |
| Net Income | -14.93M | -11.77M | -20.96M | -27.35M | -28.53M | 14.17M | -27.01M | -15.56M | -2.31M | -14.41M | -8.25M | -10.4M |
| Net Margin % | -3544.32% | -34617.65% | -13181.13% | -12211.61% | -20091.55% | 58.26% | -2365.32% | -2602.34% | -14.73% | -686.61% | -294.85% | -114.25% |
| Net Income Growth % | 47.66% | -183.04% | 22.41% | -75.77% | -1134% | 198.35% | -227.42% | -49.62% | 77.34% | -4.72% | -16.15% | 12.88% |
| Net Income (Continuing) | -14.93M | -11.77M | -20.96M | -27.35M | -28.53M | 14.17M | -27.01M | -15.56M | -2.31M | -14.41M | -8.25M | -10.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.27 | -1.32 | -1.74 | -1.80 | 0.90 | -1.71 | -0.99 | -0.16 | -1.08 | -0.66 | -0.87 |
| EPS Growth % | 81.67% | -130% | 22.81% | -75.76% | -1025% | 183.33% | -159.09% | -13.79% | 80.95% | 5.26% | 0% | 27.5% |
| EPS (Basic) | -0.33 | -0.27 | -1.32 | -1.74 | -1.80 | 0.90 | -1.71 | -0.99 | -0.16 | -1.08 | -0.66 | -0.87 |
| Diluted Shares Outstanding | 47.23M | 47.23M | 15.74M | 15.74M | 15.74M | 15.55M | 15.69M | 15.58M | 14.65M | 13.21M | 12.44M | 12.05M |
| Basic Shares Outstanding | 47.23M | 47.23M | 15.74M | 15.74M | 15.74M | 15.55M | 15.69M | 15.58M | 14.65M | 13.21M | 12.44M | 12.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |